top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
Chemielogistik : Markt, Geschäftsmodelle, Prozesse / / herausgegeben von Carsten Suntrop ; mit einem Geleitwort von Utz Tillmann
Chemielogistik : Markt, Geschäftsmodelle, Prozesse / / herausgegeben von Carsten Suntrop ; mit einem Geleitwort von Utz Tillmann
Edizione [1. Auflage.]
Pubbl/distr/stampa Weinheim : , : Wiley-VCH, , 2011
Descrizione fisica 1 online resource (356 p.)
Disciplina 338.4766
Altri autori (Persone) SuntropCarsten
Soggetto topico Chemical industry - Management
Chemical processes
ISBN 3-527-63424-X
1-283-14072-1
9786613140722
3-527-63425-8
3-527-63423-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione ger
Nota di contenuto Chemielogistik: Markt, Geschäftsmodelle, Prozesse; Geleitwort; Inhaltsverzeichnis; Vorwort; Liste der Autoren; Abkürzungsverzeichnis; I Einleitung; 1 Chemielogistik im Kontext allgemeiner logistischer Anforderungen; 1.1 Ausgangssituation der chemischen Industrie; 1.1.1 Abgrenzung der chemischen Industrie; 1.1.2 Bedeutung der chemischen Industrie; 1.1.3 Marktstrukturen der chemischen Industrie; 1.1.4 Logistik; 1.1.5 Transport- und Lagerlogistik; 1.1.6 Gefahrgüter und Gefahrstoffe; 1.1.6.1 Beförderung von Gefahrgütern; 1.1.6.2 Besonderheiten in Chemieparks; 1.1.7 Entstehung von Chemieparks
1.1.8 Entwicklung des Logistikmarktes in der Chemiebranche1.2 Sicherheit in der Transportlogistik; 1.2.1 Risiken durch vorsätzliches Handeln; 1.2.2 Risiken durch ungeplante Ereignisse; 1.3 Sicherheitsmaßnahmen in der Gefahrgutlogistik; 1.3.1 Maßnahmen zur Risikoreduzierung durch den öffentlichen Bereich; 1.3.2 Maßnahmen zur Risikoreduzierung durch Unternehmen; 1.4 Zusammenfassung; II Marktentwicklungen; 2 Marktentwicklungen und Trends; 2.1 Marktteilnehmer, Marktstrukturen und Entwicklung; 2.1.1 Strukturen, Trends und Business-Modelle von marktführenden Logistikunternehmen; 2.1.1.1 Trends
2.1.1.2 Asset-gebundene Logistikunternehmen2.1.1.3 Asset-freie Logistikunternehmen; 2.1.2 Informationslogistik. Oder: Wie reale, logistische Prozesse per innovativem Einsatz von Informations- und Kommunikationstechnik gleichzeitig effektiver und effizienter werden; 2.1.2.1 Chemiedistributoren und Trader; 2.1.3 Echtzeit-Informatisierung gesamter Logistikketten über Unternehmensgrenzen hinweg; 2.1.3.1 Geschäftsprozesse klassisch und Trends für die nähere Zukunft; 2.1.3.2 Konzerninterne Plattformen von Chemiekonzernen und Logistikanbietern
2.1.3.3 B2B-Plattformen als Konsortium und als kommerzieller Anbieter2.2 Clusterbildung; 3 Geschäftsstrategien in der Chemielogistik; 3.1 Einleitung; 3.2 Grundlagen; 3.2.1 Erarbeitung des Geschäftsmodells im Rahmen des Strategieprozesses; 3.2.2 Definition Geschäftsmodell; 3.2.3 Inhalte eines Geschäftsmodells; 3.2.4 Nutzen von Geschäftsmodellen; 3.3 Marktsituation Chemielogistik; 3.3.1 Teilnehmer im Markt Logistikdienstleistungen; 3.3.2 Herausforderungen der Marktteilnehmer; 3.4 Entwicklungsszenarien der Geschäftsmodelle in der Chemielogistik; 3.4.1 Geschäftsmodelle in der Chemielogistik
3.4.2 Entwicklungsszenarien der einzelnen Geschäftsmodelle3.4.3 Entwicklungsszenarien der einzelnen Geschäftsmodelle; 3.5 Fazit; 4 Verkehrsinfrastruktur in Zentral- und Osteuropa - Herausforderungen aus Sicht der chemischen Industrie und Logistikdienstleister; 4.1 Einleitung; 4.1.1 Projekt ChemLog - Chemical Logistics Cooperation in Central and Eastern Europe; 4.1.2 Problemstellung; 4.2 Forschungsfokus und methodische Vorgehensweise; 4.2.1 Konzept und Struktur der übergeordneten SWOT-Analyse; 4.2.2 Forschungsfokus
4.3 Verkehrsinfrastrukturelle Herausforderungen in Zentral- und Osteuropa aus Sicht der chemischen Industrie und des Logistiksektors
Record Nr. UNINA-9910830521703321
Weinheim : , : Wiley-VCH, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Chemistry entrepreneurship / / edited by Javier García-Martínez and Kunhao Li
Chemistry entrepreneurship / / edited by Javier García-Martínez and Kunhao Li
Pubbl/distr/stampa Weinheim, Germany : , : John Wiley & Sons, , [2022]
Descrizione fisica 1 online resource (291 pages)
Disciplina 338.4766
Soggetto topico Chemical industry
Entrepreneurship
Chemical workers
Soggetto genere / forma Electronic books.
ISBN 3-527-81987-8
3-527-81986-X
3-527-81985-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title Page -- Copyright -- Contents -- Foreword -- Preface -- Chapter 1 We Need An Entrepreneurial Culture in Chemistry: Do You Have What It Takes to be a Chemistry Entrepreneur? -- 1.1 Introduction: Disruptive Innovation in Chemistry is in High Demand -- 1.2 Examples of Innovation in Chemistry Catching the Eye of the Mainstream Market -- 1.2.1 Food and Nutrition -- 1.2.1.1 Just (formerly Hampton Creek) -- 1.2.1.2 Impossible Foods -- 1.2.1.3 Perfect Day -- 1.2.1.4 Endless West (formerly Ava Winery) -- 1.2.2 Sustainable/Renewable Chemistry -- 1.2.2.1 Ginkgo Bioworks -- 1.2.2.2 Modern Meadow -- 1.2.2.3 Genomatica -- 1.2.2.4 Zymergen -- 1.2.3 Biotech/Pharma -- 1.2.3.1 Moderna Therapeutics -- 1.2.3.2 Unity Biotechnology -- 1.2.3.3 CRISPR Therapeutics, Intellia Therapeutics, and Editas Medicine -- 1.2.4 Diagnostics -- 1.2.4.1 23andme -- 1.2.4.2 Grail Diagnostics -- 1.2.4.3 Viome -- 1.2.5 Cautionary Tales -- 1.2.5.1 Theranos -- 1.2.5.2 Solazyme (TerraVia) -- 1.3 Unique Challenges for Chemistry Entrepreneurs -- 1.3.1 The Most Important Trait of Every Chemical Entrepreneur -- 1.3.2 Chemistry Accelerators, Incubators, and Academic Spin‐offs -- 1.3.3 Do Something, do Anything, even if it is Wrong -- 1.3.3.1 Penicillin -- 1.3.3.2 Post‐It -- 1.3.3.3 Saccharin -- 1.3.3.4 Teflon -- 1.3.3.5 Viagra -- 1.3.4 You have your Discovery -- now you need a Patent -- 1.3.4.1 Provisional Patent -- 1.3.4.2 Patent Application -- 1.3.4.3 Patent Prosecution -- 1.3.4.4 Structure of the Patent Claims -- 1.3.4.5 Patent Search and Prior Art -- 1.3.4.6 Publishing Before Patenting -- 1.3.4.7 PCT International Patent -- 1.3.4.8 Protectable Patent Value -- 1.3.4.9 Selecting the Wrong Lawyer for the Job -- 1.4 Invention is Only the Beginning of Creating a Company -- 1.4.1 Know your Role: Founding CEO vs. Founder vs. Inventor.
1.4.2 Raising Money: Acquiring the Right Money at the Right Time -- 1.4.2.1 Self‐funding -- 1.4.2.2 Friends and Family -- 1.4.2.3 Angel Investors -- 1.4.2.4 Accelerators and Incubators -- 1.4.2.5 Debt -- 1.4.2.6 Strategic Investment -- 1.4.2.7 Private Equity -- 1.4.2.8 Venture Capital -- 1.4.2.9 Investment Banks -- 1.4.3 Can you get the idea for Commercialization? -- 1.4.4 When you are Ready to Commercialize, which path do you take? -- 1.4.4.1 Licensing Deal -- 1.4.4.2 Business‐to‐Business (B2B) -- 1.4.4.3 Business‐to‐Consumer (B2C) -- 1.5 Do you have the Traits of an Entrepreneur? -- 1.6 Summary: Do You Have What It Takes? -- Recommended Readings and References -- Author Biography -- Chapter 2 Taking Ideas Out of the Lab: Why and When to Start a Company in the Biomedical Field -- 2.1 Introduction -- 2.2 Company Case Studies: Interviews with the Founding Scientists -- 2.2.1 Advanced Inhalation Research: Interview with David Edwards -- 2.2.1.1 Core Technology -- 2.2.1.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.1.3 Why was it Important to Start Advanced Inhalation Research? -- 2.2.1.4 When was the Technology Ready to Start Advanced Inhalation Research? -- 2.2.1.5 What Lessons Did You Learn Through This Process? -- 2.2.1.6 Current Status -- 2.2.2 Kala Pharmaceuticals: Interview with Justin Hanes -- 2.2.2.1 Core Technology -- 2.2.2.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.2.3 Why was it Important to Start Kala Pharmaceuticals? -- 2.2.2.4 When was the Technology Ready to Start Kala Pharmaceuticals? -- 2.2.2.5 What Lessons Did You Learn Through This Process? -- 2.2.2.6 Current Status -- 2.2.3 Moderna: Interview with Derrick Rossi -- 2.2.3.1 Core Technology -- 2.2.3.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.3.3 Why was it Important to Start Moderna?.
2.2.3.4 When was the Technology Ready to Start Moderna? -- 2.2.3.5 What Lessons Did You Learn Through This Process? -- 2.2.3.6 Current Status -- 2.2.4 Sigilon Therapeutics: Interview with Arturo Vegas -- 2.2.4.1 Core Technology -- 2.2.4.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.4.3 Why was it Important to Start Sigilon? -- 2.2.4.4 When was the Technology Ready to Start Sigilon? -- 2.2.4.5 What Lessons Did You Learn Through This Process? -- 2.2.4.6 Current Status -- 2.2.5 Suono Bio: Interview with Carl Schoellhammer -- 2.2.5.1 Core Technology -- 2.2.5.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.5.3 Why was it Important to Start Suono Bio? -- 2.2.5.4 When was the Technology Ready to Start Suono Bio? -- 2.2.5.5 What Lessons Did You Learn Through This Process? -- 2.2.5.6 Current Status -- 2.2.6 Vivtex: Interview with Thomas von Erlach -- 2.2.6.1 Core Technology -- 2.2.6.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.6.3 Why was it Important to Start Vivtex? -- 2.2.6.4 When was the Technology Ready to Vivtex? -- 2.2.6.5 What Lessons Did You Learn Through This Process? -- 2.2.6.6 Current Status -- 2.3 Why Start a Company? -- 2.3.1 To Have the Largest Impact on Patients -- 2.3.2 To Introduce a New Platform Technology -- 2.3.3 Is Licensing an Alternative? -- 2.3.3.1 Licensing to Existing Companies -- 2.3.3.2 Corporate‐sponsored Academic Research -- 2.4 When to Start a Company? -- 2.4.1 Is There Enough In Vivo Validation? -- 2.4.2 Was a Patent Filed? -- 2.4.3 Was a Paper Published? -- 2.5 The Secret Ingredient: Who and What? -- 2.5.1 Who Will Start the Company? -- 2.5.1.1 Seasoned Mentors as Co‐founders -- 2.5.1.2 Finding a Great CEO -- 2.5.2 What Will the Company Actually Sell? -- 2.6 Summary: Lessons Learned -- 2.6.1 Lesson 1: Work on a High‐impact, Platform Technology.
2.6.2 Lesson 2: Patent Early and Broadly -- 2.6.3 Lesson 3: Keep the Tech in the Lab as Long as Possible -- 2.6.4 Lesson 4: Must have in vivo Efficacy and Safety -- 2.6.5 Lesson 5: Publish in Top Scientific Journals -- 2.6.6 Lesson 6: Partner with Seasoned Entrepreneurs -- Further Reading -- Author Biographies -- Chapter 3 In Pursuit of New Product Opportunities: Transferring Technology from Lab to Market -- 3.1 Introduction -- 3.1.1 Entrepreneurship and Technology Transfer -- 3.1.2 Pursuing Commercial Product/Service Opportunities via Technology Transfer -- 3.1.3 A Model for Entrepreneurship via Technology Transfer -- 3.1.4 Extracting Technologies from Research Institutions -- 3.2 Technology Discovery and Development -- 3.2.1 Origins of Technology -- 3.2.2 Technology Transfer Communication Models -- 3.2.3 Transitioning Technologies into Products -- 3.2.4 Timing Technology with Industry Acceptance -- 3.3 Customer Discovery and Development -- 3.3.1 Origins of Market Demand and Unmet Needs -- 3.3.2 Identifying a Technology's Uses -- 3.3.3 The Value Chain for Target Applications -- 3.3.4 Identifying Stakeholders in the Value Chain -- 3.3.5 Designing Product Experiments -- 3.3.6 Customer Discovery and Validation Model -- 3.3.6.1 Customer Routines Analysis -- 3.4 Case Study: The Naval Research Laboratory's Self‐Decontaminating Material -- 3.4.1 The Challenge -- 3.4.2 The Scientist -- 3.4.3 The Problem -- 3.4.4 The Solution -- 3.4.5 The Future of the Technology and Future Applications -- 3.4.6 Technology Background and Advantages -- 3.4.7 Benefits -- 3.4.8 Problem -- 3.4.9 Technical Approach -- 3.4.10 Solution -- 3.4.11 Industrial Safety and Hygiene -- 3.4.12 Healthcare and Pharmaceuticals -- 3.4.13 First Response -- Suggested Reading and Resources -- Author Biography -- Chapter 4 Financing and Business Development for Hard Tech Startups.
4.1 Introduction -- 4.2 Challenges in Financing Hard Tech Startups -- 4.2.1 Balancing Ambition with Reality -- 4.2.2 Hard Tech Sure Is Not Software -- 4.2.3 Hard Tech Investors Are a Skeptical Bunch -- 4.2.4 What Do You Mean I Will Not Exit for 1B? -- 4.2.5 Hard Tech Fundraising Dissonance -- 4.3 Fundraising the Right Way -- 4.3.1 What Kind of Investors Should You Raise from? -- 4.3.1.1 Friends and Family -- 4.3.1.2 Angels -- 4.3.1.3 Early‐Stage Institutional Venture Capitalists -- 4.3.1.4 Late‐Stage Institutional Venture Capitalists -- 4.3.1.5 Corporate Venture Capital -- 4.3.2 Venture Capital Uncovered -- 4.3.2.1 Fund Life -- 4.3.2.2 Return the Fund -- 4.3.2.3 The Mythical 10× and Why It Is Important to You -- 4.3.3 How to Generate Interest from Investors? -- 4.3.3.1 Team -- 4.3.3.2 Differentiated Technology and Customer Value Proposition -- 4.3.3.3 Large Target Market -- 4.3.3.4 Compelling Plan to Build a Business -- 4.4 The Case for Early‐Stage Business Development -- 4.4.1.1 Playbook for Early‐Stage Business Development -- 4.4.1.2 Getting Started -- 4.4.1.3 Getting to the Finish Line -- 4.4.1.4 Avoiding Common Pitfalls -- 4.5 Summary -- Suggested Reading -- Author Biographies -- Chapter 5 Battery Entrepreneurship: Gameboard from Lab to Market -- 5.1 Introduction -- 5.2 Finding a Market Fit for Your Technology -- 5.3 Energy Storage Markets -- 5.3.1 Portable Electronics, Drones, and Medical Devices -- 5.3.2 Grid Energy Storage and Renewable Energy -- 5.3.3 Industrial Batteries and Back‐up Power -- 5.3.4 Home Energy Storage -- 5.3.5 Electric Vehicles -- 5.3.5.1 Passenger Cars -- 5.3.5.2 Light Electric Utility Vehicles -- 5.3.5.3 Heavy‐duty Utility Vehicles, Trucks, and Buses -- 5.3.6 Other Nascent Energy Storage Markets -- 5.3.7 Airplanes -- 5.3.8 Ships and Boats -- 5.4 Battery Startup Case Studies -- 5.4.1 Boston Power -- 5.4.2 A123 Systems.
5.4.3 Aquion Energy.
Record Nr. UNINA-9910554802703321
Weinheim, Germany : , : John Wiley & Sons, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Chemistry entrepreneurship / / edited by Javier García-Martínez and Kunhao Li
Chemistry entrepreneurship / / edited by Javier García-Martínez and Kunhao Li
Pubbl/distr/stampa Weinheim, Germany : , : John Wiley & Sons, , [2022]
Descrizione fisica 1 online resource (291 pages)
Disciplina 338.4766
Soggetto topico Chemical industry
Entrepreneurship
Chemical workers
ISBN 3-527-81987-8
3-527-81986-X
3-527-81985-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title Page -- Copyright -- Contents -- Foreword -- Preface -- Chapter 1 We Need An Entrepreneurial Culture in Chemistry: Do You Have What It Takes to be a Chemistry Entrepreneur? -- 1.1 Introduction: Disruptive Innovation in Chemistry is in High Demand -- 1.2 Examples of Innovation in Chemistry Catching the Eye of the Mainstream Market -- 1.2.1 Food and Nutrition -- 1.2.1.1 Just (formerly Hampton Creek) -- 1.2.1.2 Impossible Foods -- 1.2.1.3 Perfect Day -- 1.2.1.4 Endless West (formerly Ava Winery) -- 1.2.2 Sustainable/Renewable Chemistry -- 1.2.2.1 Ginkgo Bioworks -- 1.2.2.2 Modern Meadow -- 1.2.2.3 Genomatica -- 1.2.2.4 Zymergen -- 1.2.3 Biotech/Pharma -- 1.2.3.1 Moderna Therapeutics -- 1.2.3.2 Unity Biotechnology -- 1.2.3.3 CRISPR Therapeutics, Intellia Therapeutics, and Editas Medicine -- 1.2.4 Diagnostics -- 1.2.4.1 23andme -- 1.2.4.2 Grail Diagnostics -- 1.2.4.3 Viome -- 1.2.5 Cautionary Tales -- 1.2.5.1 Theranos -- 1.2.5.2 Solazyme (TerraVia) -- 1.3 Unique Challenges for Chemistry Entrepreneurs -- 1.3.1 The Most Important Trait of Every Chemical Entrepreneur -- 1.3.2 Chemistry Accelerators, Incubators, and Academic Spin‐offs -- 1.3.3 Do Something, do Anything, even if it is Wrong -- 1.3.3.1 Penicillin -- 1.3.3.2 Post‐It -- 1.3.3.3 Saccharin -- 1.3.3.4 Teflon -- 1.3.3.5 Viagra -- 1.3.4 You have your Discovery -- now you need a Patent -- 1.3.4.1 Provisional Patent -- 1.3.4.2 Patent Application -- 1.3.4.3 Patent Prosecution -- 1.3.4.4 Structure of the Patent Claims -- 1.3.4.5 Patent Search and Prior Art -- 1.3.4.6 Publishing Before Patenting -- 1.3.4.7 PCT International Patent -- 1.3.4.8 Protectable Patent Value -- 1.3.4.9 Selecting the Wrong Lawyer for the Job -- 1.4 Invention is Only the Beginning of Creating a Company -- 1.4.1 Know your Role: Founding CEO vs. Founder vs. Inventor.
1.4.2 Raising Money: Acquiring the Right Money at the Right Time -- 1.4.2.1 Self‐funding -- 1.4.2.2 Friends and Family -- 1.4.2.3 Angel Investors -- 1.4.2.4 Accelerators and Incubators -- 1.4.2.5 Debt -- 1.4.2.6 Strategic Investment -- 1.4.2.7 Private Equity -- 1.4.2.8 Venture Capital -- 1.4.2.9 Investment Banks -- 1.4.3 Can you get the idea for Commercialization? -- 1.4.4 When you are Ready to Commercialize, which path do you take? -- 1.4.4.1 Licensing Deal -- 1.4.4.2 Business‐to‐Business (B2B) -- 1.4.4.3 Business‐to‐Consumer (B2C) -- 1.5 Do you have the Traits of an Entrepreneur? -- 1.6 Summary: Do You Have What It Takes? -- Recommended Readings and References -- Author Biography -- Chapter 2 Taking Ideas Out of the Lab: Why and When to Start a Company in the Biomedical Field -- 2.1 Introduction -- 2.2 Company Case Studies: Interviews with the Founding Scientists -- 2.2.1 Advanced Inhalation Research: Interview with David Edwards -- 2.2.1.1 Core Technology -- 2.2.1.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.1.3 Why was it Important to Start Advanced Inhalation Research? -- 2.2.1.4 When was the Technology Ready to Start Advanced Inhalation Research? -- 2.2.1.5 What Lessons Did You Learn Through This Process? -- 2.2.1.6 Current Status -- 2.2.2 Kala Pharmaceuticals: Interview with Justin Hanes -- 2.2.2.1 Core Technology -- 2.2.2.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.2.3 Why was it Important to Start Kala Pharmaceuticals? -- 2.2.2.4 When was the Technology Ready to Start Kala Pharmaceuticals? -- 2.2.2.5 What Lessons Did You Learn Through This Process? -- 2.2.2.6 Current Status -- 2.2.3 Moderna: Interview with Derrick Rossi -- 2.2.3.1 Core Technology -- 2.2.3.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.3.3 Why was it Important to Start Moderna?.
2.2.3.4 When was the Technology Ready to Start Moderna? -- 2.2.3.5 What Lessons Did You Learn Through This Process? -- 2.2.3.6 Current Status -- 2.2.4 Sigilon Therapeutics: Interview with Arturo Vegas -- 2.2.4.1 Core Technology -- 2.2.4.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.4.3 Why was it Important to Start Sigilon? -- 2.2.4.4 When was the Technology Ready to Start Sigilon? -- 2.2.4.5 What Lessons Did You Learn Through This Process? -- 2.2.4.6 Current Status -- 2.2.5 Suono Bio: Interview with Carl Schoellhammer -- 2.2.5.1 Core Technology -- 2.2.5.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.5.3 Why was it Important to Start Suono Bio? -- 2.2.5.4 When was the Technology Ready to Start Suono Bio? -- 2.2.5.5 What Lessons Did You Learn Through This Process? -- 2.2.5.6 Current Status -- 2.2.6 Vivtex: Interview with Thomas von Erlach -- 2.2.6.1 Core Technology -- 2.2.6.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.6.3 Why was it Important to Start Vivtex? -- 2.2.6.4 When was the Technology Ready to Vivtex? -- 2.2.6.5 What Lessons Did You Learn Through This Process? -- 2.2.6.6 Current Status -- 2.3 Why Start a Company? -- 2.3.1 To Have the Largest Impact on Patients -- 2.3.2 To Introduce a New Platform Technology -- 2.3.3 Is Licensing an Alternative? -- 2.3.3.1 Licensing to Existing Companies -- 2.3.3.2 Corporate‐sponsored Academic Research -- 2.4 When to Start a Company? -- 2.4.1 Is There Enough In Vivo Validation? -- 2.4.2 Was a Patent Filed? -- 2.4.3 Was a Paper Published? -- 2.5 The Secret Ingredient: Who and What? -- 2.5.1 Who Will Start the Company? -- 2.5.1.1 Seasoned Mentors as Co‐founders -- 2.5.1.2 Finding a Great CEO -- 2.5.2 What Will the Company Actually Sell? -- 2.6 Summary: Lessons Learned -- 2.6.1 Lesson 1: Work on a High‐impact, Platform Technology.
2.6.2 Lesson 2: Patent Early and Broadly -- 2.6.3 Lesson 3: Keep the Tech in the Lab as Long as Possible -- 2.6.4 Lesson 4: Must have in vivo Efficacy and Safety -- 2.6.5 Lesson 5: Publish in Top Scientific Journals -- 2.6.6 Lesson 6: Partner with Seasoned Entrepreneurs -- Further Reading -- Author Biographies -- Chapter 3 In Pursuit of New Product Opportunities: Transferring Technology from Lab to Market -- 3.1 Introduction -- 3.1.1 Entrepreneurship and Technology Transfer -- 3.1.2 Pursuing Commercial Product/Service Opportunities via Technology Transfer -- 3.1.3 A Model for Entrepreneurship via Technology Transfer -- 3.1.4 Extracting Technologies from Research Institutions -- 3.2 Technology Discovery and Development -- 3.2.1 Origins of Technology -- 3.2.2 Technology Transfer Communication Models -- 3.2.3 Transitioning Technologies into Products -- 3.2.4 Timing Technology with Industry Acceptance -- 3.3 Customer Discovery and Development -- 3.3.1 Origins of Market Demand and Unmet Needs -- 3.3.2 Identifying a Technology's Uses -- 3.3.3 The Value Chain for Target Applications -- 3.3.4 Identifying Stakeholders in the Value Chain -- 3.3.5 Designing Product Experiments -- 3.3.6 Customer Discovery and Validation Model -- 3.3.6.1 Customer Routines Analysis -- 3.4 Case Study: The Naval Research Laboratory's Self‐Decontaminating Material -- 3.4.1 The Challenge -- 3.4.2 The Scientist -- 3.4.3 The Problem -- 3.4.4 The Solution -- 3.4.5 The Future of the Technology and Future Applications -- 3.4.6 Technology Background and Advantages -- 3.4.7 Benefits -- 3.4.8 Problem -- 3.4.9 Technical Approach -- 3.4.10 Solution -- 3.4.11 Industrial Safety and Hygiene -- 3.4.12 Healthcare and Pharmaceuticals -- 3.4.13 First Response -- Suggested Reading and Resources -- Author Biography -- Chapter 4 Financing and Business Development for Hard Tech Startups.
4.1 Introduction -- 4.2 Challenges in Financing Hard Tech Startups -- 4.2.1 Balancing Ambition with Reality -- 4.2.2 Hard Tech Sure Is Not Software -- 4.2.3 Hard Tech Investors Are a Skeptical Bunch -- 4.2.4 What Do You Mean I Will Not Exit for 1B? -- 4.2.5 Hard Tech Fundraising Dissonance -- 4.3 Fundraising the Right Way -- 4.3.1 What Kind of Investors Should You Raise from? -- 4.3.1.1 Friends and Family -- 4.3.1.2 Angels -- 4.3.1.3 Early‐Stage Institutional Venture Capitalists -- 4.3.1.4 Late‐Stage Institutional Venture Capitalists -- 4.3.1.5 Corporate Venture Capital -- 4.3.2 Venture Capital Uncovered -- 4.3.2.1 Fund Life -- 4.3.2.2 Return the Fund -- 4.3.2.3 The Mythical 10× and Why It Is Important to You -- 4.3.3 How to Generate Interest from Investors? -- 4.3.3.1 Team -- 4.3.3.2 Differentiated Technology and Customer Value Proposition -- 4.3.3.3 Large Target Market -- 4.3.3.4 Compelling Plan to Build a Business -- 4.4 The Case for Early‐Stage Business Development -- 4.4.1.1 Playbook for Early‐Stage Business Development -- 4.4.1.2 Getting Started -- 4.4.1.3 Getting to the Finish Line -- 4.4.1.4 Avoiding Common Pitfalls -- 4.5 Summary -- Suggested Reading -- Author Biographies -- Chapter 5 Battery Entrepreneurship: Gameboard from Lab to Market -- 5.1 Introduction -- 5.2 Finding a Market Fit for Your Technology -- 5.3 Energy Storage Markets -- 5.3.1 Portable Electronics, Drones, and Medical Devices -- 5.3.2 Grid Energy Storage and Renewable Energy -- 5.3.3 Industrial Batteries and Back‐up Power -- 5.3.4 Home Energy Storage -- 5.3.5 Electric Vehicles -- 5.3.5.1 Passenger Cars -- 5.3.5.2 Light Electric Utility Vehicles -- 5.3.5.3 Heavy‐duty Utility Vehicles, Trucks, and Buses -- 5.3.6 Other Nascent Energy Storage Markets -- 5.3.7 Airplanes -- 5.3.8 Ships and Boats -- 5.4 Battery Startup Case Studies -- 5.4.1 Boston Power -- 5.4.2 A123 Systems.
5.4.3 Aquion Energy.
Record Nr. UNINA-9910830498603321
Weinheim, Germany : , : John Wiley & Sons, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The company that changed itself : R&D and the transformations of DSM / / Arjan van Rooij
The company that changed itself : R&D and the transformations of DSM / / Arjan van Rooij
Autore Rooij Arjan van
Edizione [1st ed.]
Pubbl/distr/stampa Amsterdam, : Amsterdam University Press, 2007
Descrizione fisica 1 online resource (319 p.)
Disciplina 338.4766
900
Soggetto topico Chemical industry - Research - Netherlands
Research, Industrial - Netherlands
ISBN 1-281-78778-7
9786611787783
90-485-0165-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Table of Contents; Foreword; Preface; 1. Introduction: Research and Business in the Chemical Industry; 2. From Works Laboratories to Centralized Research; 3. Expansion and Diversification: R & D after the Second World War; 4. The Large Leap Forward: Redefining the Role of R&D in the 1970's; 5. The 1980's: Moving Away from Cyclicality and into High Value-Added Products; 6. Conclusion: Research and Business at DSM; 7. Epilogue: the 1990's; Appendix; Sources; List of Figures, Graphs and Tables; Index
Altri titoli varianti R&D and the transformations of DSM
Record Nr. UNINA-9910144106203321
Rooij Arjan van  
Amsterdam, : Amsterdam University Press, 2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Comunicación de riesgo y estudio de caso : los polígonos químico Españoles / / Encarnación Rodríguez Perea ; prólogo de Josep Bertran i Gimferrer
Comunicación de riesgo y estudio de caso : los polígonos químico Españoles / / Encarnación Rodríguez Perea ; prólogo de Josep Bertran i Gimferrer
Autore Rodríguez Perea Encarnación
Pubbl/distr/stampa Barcelona : , : Editorial UOC, , [2016]
Descrizione fisica 1 online resource (290 páginas)
Disciplina 338.4766
Collana Dircom colección
Soggetto topico Chemical industry
Chemical industry - Spain
Risk communication
ISBN 84-9116-504-5
84-9116-503-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione spa
Record Nr. UNINA-9910792543703321
Rodríguez Perea Encarnación  
Barcelona : , : Editorial UOC, , [2016]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Comunicación de riesgo y estudio de caso : los polígonos químico Españoles / / Encarnación Rodríguez Perea ; prólogo de Josep Bertran i Gimferrer
Comunicación de riesgo y estudio de caso : los polígonos químico Españoles / / Encarnación Rodríguez Perea ; prólogo de Josep Bertran i Gimferrer
Autore Rodríguez Perea Encarnación
Pubbl/distr/stampa Barcelona : , : Editorial UOC, , [2016]
Descrizione fisica 1 online resource (290 páginas)
Disciplina 338.4766
Collana Dircom colección
Soggetto topico Chemical industry
Chemical industry - Spain
Risk communication
ISBN 84-9116-504-5
84-9116-503-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione spa
Record Nr. UNINA-9910827551703321
Rodríguez Perea Encarnación  
Barcelona : , : Editorial UOC, , [2016]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
L'economia delle imprese dolciarie / Umberto Bocchino
L'economia delle imprese dolciarie / Umberto Bocchino
Autore Bocchino, Umberto
Pubbl/distr/stampa Milano : Giuffrè, 1993
Descrizione fisica XI, 236 p. ; 25 cm
Disciplina 338.4766
Collana Università degli studi di Torino, Istituto di ragioneria ed economia aziendale Giovanni Ferrero. Serie 3 ; 3
Soggetto topico Industria dolciaria - Italia
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione ita
Record Nr. UNISALENTO-991000314879707536
Bocchino, Umberto  
Milano : Giuffrè, 1993
Materiale a stampa
Lo trovi qui: Univ. del Salento
Opac: Controlla la disponibilità qui
Formazione e lavoro nel settore agroalimentare in Europa / a cura di Gabriella Pappadà ; con contributi di Luca Antonazzo ... [et al.]
Formazione e lavoro nel settore agroalimentare in Europa / a cura di Gabriella Pappadà ; con contributi di Luca Antonazzo ... [et al.]
Pubbl/distr/stampa Milano : FrancoAngeli, 2010
Descrizione fisica 152 p. ; 24 cm
Disciplina 338.4766
Collana Quaderni di economia del lavoro
ISBN 978-88-568-3290-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione ita
Record Nr. UNINA-990009326990403321
Milano : FrancoAngeli, 2010
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
IEEE Std 1068-2009 (Revision of IEEE Std 1068-1996) - Redline / / Institute of Electrical and Electronics Engineers
IEEE Std 1068-2009 (Revision of IEEE Std 1068-1996) - Redline / / Institute of Electrical and Electronics Engineers
Pubbl/distr/stampa [Place of publication not identified] : , : IEEE, , 2010
Descrizione fisica 1 online resource (79 pages)
Disciplina 338.4766
Soggetto topico Chemical industry
Chemical industry - History
ISBN 0-7381-5486-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti IEEE Std 1068-2009 (Revision of IEEE Std 1068-1996) - Redline: IEEE Standard for the Repair and Rewinding of AC Electric Motors in the Petroleum, Chemical, and Process Industries - Redline
IEEE Std 1068-2009
Record Nr. UNISA-996280501403316
[Place of publication not identified] : , : IEEE, , 2010
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
IEEE Std 1068-2009 (Revision of IEEE Std 1068-1996) - Redline / / Institute of Electrical and Electronics Engineers
IEEE Std 1068-2009 (Revision of IEEE Std 1068-1996) - Redline / / Institute of Electrical and Electronics Engineers
Pubbl/distr/stampa [Place of publication not identified] : , : IEEE, , 2010
Descrizione fisica 1 online resource (79 pages)
Disciplina 338.4766
Soggetto topico Chemical industry
Chemical industry - History
ISBN 0-7381-5486-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti IEEE Std 1068-2009 (Revision of IEEE Std 1068-1996) - Redline: IEEE Standard for the Repair and Rewinding of AC Electric Motors in the Petroleum, Chemical, and Process Industries - Redline
IEEE Std 1068-2009
Record Nr. UNINA-9910135895503321
[Place of publication not identified] : , : IEEE, , 2010
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui